In December, Materialise announced a partnership with Tissue Regeneration Systems (TRS) to manufacture 3D-printed tracheal splints for use in clinical trials Materialise will undertake with the University of Michigan in a separate exclusive licensing agreement. The company plans to ultimately offer the newly granted patent in the marketplace.

Radiation therapy was associated with a lower risk of cancer recurrence in pancreatic cancer surgery patients, making it, like chemotherapy, an important addition to treatment, Mayo Clinic research found. Whether radiotherapy helps patients after pancreatic cancer surgery has been a long-standing question, and the findings suggest that it does, said senior author Christopher Hallemeier, M.D., a radiation oncologist at the Mayo Clinic Cancer Center. The study is published in the American Society for Radiation Oncology’s International Journal of Radiation Oncology, Biology, Physics.

Carestream Health is receiving orders for its Carestream Touch Prime and Touch Prime XE ultrasound systems in the United States and Europe, which were expected to begin shipping in December. A Health Canada license is pending.

December 31, 2015 — Volpara Solutions has gone mobile with the first-ever installation of VolparaDensity in a mobile ...

Patients with prostate cancer are now being treated with minimally invasive, high intensity focused ultrasound (HIFU) therapy, following the October 2015 U.S. Food and Drug Administration (FDA) regulatory authorization for prostate tissue ablation with the Sonablate HIFU device.

Smart Choice MRI, the first MRI provider in the country to offer high quality Magnetic Resonance Imaging (MRIs) to patients for an affordable rate of $600 or less, today announced it has raised $6.5 million in growth capital.